Luye Pharma Group Limited — Interim / Quarterly Report 2001

Nov 23, 2000

Listed Company Information

TAKSON HOLDINGS<0918> - Results Announcement Takson Holdings Limited nnounced on 23/11/2000: (stock code: 918) Year end date: 31/3/2001 Currency: HKD (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/4/2000 from 1/4/1999 to 30/9/2000 to 30/9/1999 Turnover : 419,011,000 356,150,000 Profit/(Loss) from Operations : 32,076,000 72,250,000 Finance cost : (7,352,000) (4,374,000) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : (1,165,000) N/A Profit/(Loss) after Tax & MI : 20,767,000 59,525,000 % Change over Last Period : -65% EPS/(LPS)-Basic : 0.0554 0.1653 -Diluted : 0.0531 0.1557 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 20,767,000 59,525,000 Interim Dividend per Share : Nil 0.01 (Specify if with other options) : N/A N/A B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remarks: 1. Comparative figures As a result of the adoption of the revised Hong Kong Statement of Standard Accounting Practice 1, certain comparative figures have been reclassified to conform with current period's presentation. 2. Earnings per share The calculation of basic and diluted earnings per share are based on the profit attributable to shareholders of HK$20,767,000 (1999: HK$59,525,000). The basic earnings per share is based on the weighted average number of 374,600,000 (1999: 360,000,000) ordinary shares in issue during the period. The diluted earnings per share is based on 374,600,000 (1999: 360,000,000) ordinary shares which is the weighted average number of ordinary shares in issue during the period plus the weighted average number of 16,575,472 (1999: 22,271,679) ordinary shares deemed to be issued at no consideration if all outstanding options had been exercised.